Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,391.97
(
-0.12%
)
US TECH 100
28,248.00
(
-0.15%
)
Dow Jones
49,526.49
(
-0.47%
)
Brent Oil
105.82
(
0.05%
)
Bitcoin
79,702.60
(
-0.98%
)
News Focus
News Focus
Post# of 825900
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 92
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: scotty3371 post# 818280

Wednesday, 03/18/2026 8:21:45 AM

Wednesday, March 18, 2026 8:21:45 AM

Post# of 825900

The mhra is swell with nwbo to continue its use of dcvax within its specials program but is unwilling to approve it.
Makes perfect sense to me.


Specials has no evaluations of the drugs at all. Not even safety. P1/2 trials not required. Not even pre-clinical work. All that is required is GMP and marketing restrictions.

But never let reality get in the way of your argument.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News